These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Albinism and evoked potentials: factors in the selection of infrahuman models in predicting the human response to neurotoxic agents. Creel DJ Neurobehav Toxicol Teratol; 1984; 6(6):447-53. PubMed ID: 6531050 [TBL] [Abstract][Full Text] [Related]
3. Cross species extrapolation and hazard identification in neurotoxicology. Dyer RS Neurobehav Toxicol Teratol; 1984; 6(6):409-11. PubMed ID: 6531047 [No Abstract] [Full Text] [Related]
4. The late positive component of the evoked cortical potential: application to neurotoxicity testing. Harbin TJ Neurobehav Toxicol Teratol; 1985; 7(4):339-44. PubMed ID: 3903531 [TBL] [Abstract][Full Text] [Related]
6. [Current state of studies on the effect of organic solvents on the nervous system]. Sińczuk-Walczak H Med Pr; 1992; 43(6):543-8. PubMed ID: 1296115 [TBL] [Abstract][Full Text] [Related]
7. EEG as a cross species indicator of neurotoxicity. Benignus VA Neurobehav Toxicol Teratol; 1984; 6(6):473-83. PubMed ID: 6531053 [TBL] [Abstract][Full Text] [Related]
8. Principles of developmental neurotoxicology. Slikker W Neurotoxicology; 1994; 15(1):11-6. PubMed ID: 8090351 [TBL] [Abstract][Full Text] [Related]
9. Psychophysical testing in human populations exposed to neurotoxicants. Maurissen JP Neurobehav Toxicol Teratol; 1985; 7(4):309-17. PubMed ID: 2997637 [TBL] [Abstract][Full Text] [Related]
10. Dose/effect relationships in developmental neurotoxicology. Nelson BK Neurobehav Toxicol Teratol; 1981; 3(3):255. PubMed ID: 7290278 [No Abstract] [Full Text] [Related]
11. [Contingent negative variation: neurophysiological, psychological and clinical aspects of a new method of electroencephalographic research in man. (Critical review)]. Papini M; Zappoli R Riv Neurol; 1972; 42(4):380-419. PubMed ID: 4560872 [No Abstract] [Full Text] [Related]
12. Clinical, socio-demographic, neurophysiological and neuropsychiatric evaluation of children with volatile substance addiction. Uzun N; Kendirli Y Child Care Health Dev; 2005 Jul; 31(4):425-32. PubMed ID: 15948879 [TBL] [Abstract][Full Text] [Related]
13. An approach to brief field testing for neurotoxicity. Eckerman DA; Carroll JB; Foree D; Gullion CM; Lansman M; Long ER; Waller MB; Wallsten TS Neurobehav Toxicol Teratol; 1985; 7(4):387-93. PubMed ID: 4058647 [TBL] [Abstract][Full Text] [Related]
14. Monitoring of sensory evoked potentials during neurosurgical operations: methods and applications. Grundy BL Neurosurgery; 1982 Oct; 11(4):556-75. PubMed ID: 6755296 [TBL] [Abstract][Full Text] [Related]
15. Topography of the post-imperative negative variation in schizophrenic patients and controls obtained from high-resolution ERP maps. Rockstroh B; Cohen R; Hauk O; Dobel C; Berg P; Horvat J; Elbert T Electroencephalogr Clin Neurophysiol Suppl; 1999; 49():210-4. PubMed ID: 10533112 [No Abstract] [Full Text] [Related]
17. Adult versus developmental neurotoxicology: an occupational perspective of similarities and differences. Nelson BK Neurotoxicol Teratol; 1994; 16(2):213-8. PubMed ID: 8052196 [TBL] [Abstract][Full Text] [Related]
18. Applications of cognitive ERPs in neurosurgical and neurological patients. Curry SH; Woods DL; Low MD Electroencephalogr Clin Neurophysiol Suppl; 1986; 38():469-84. PubMed ID: 3466781 [No Abstract] [Full Text] [Related]
19. Neurobehavioral toxicology in the 21st century: a future or a failure? The 1991 Hänninen Lecture. Johnson BL Environ Res; 1993 Jul; 62(1):114-24. PubMed ID: 8325257 [TBL] [Abstract][Full Text] [Related]